All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @onlyjayanne on TikTok · 90s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @onlyjayanne's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright guys, so I reconstituted my peptide last night.
  2. 0:04I'll show you guys what it looks like.
  3. 0:06I haven't seen it since I reconstituted it.
  4. 0:10But let's see it.
  5. 0:13It's right over here.
  6. 0:15I got my AOD from peptide Pro.
  7. 0:17It's making my bio.
  8. 0:20Again this is the first time I'm going to...
  9. 0:22Oh yes, looks good.
  10. 0:23Looks amazing.
  11. 0:25Looks clear.
  12. 0:28It does not look like it's gelled up or whatsoever.
  13. 0:32It's a little foggy because of, you know, the fridge.
  14. 0:38But looks amazing.
  15. 0:40Looks beautiful.
  16. 0:42If you guys are looking into reconstituting your own AOD, make sure that you add acetic
  17. 0:48acid so it doesn't...
  18. 0:50It doesn't gel up because the very first time that I reconstituted my AOD, I only put acetic...
  19. 0:57Oh, I only put back water and a little bit of acetic acid and that kind of like messed
  20. 1:06up my peptide.
  21. 1:08But I did fix it by adding a little bit more acetic acid.
  22. 1:13And y'all.
  23. 1:14So I learned my lesson.
  24. 1:16Make sure you add acetic acid.
  25. 1:18That is all.
  26. 1:19Love this.
  27. 1:20Look at that.
  28. 1:23It's clear.
  29. 1:24It's beautiful.
  30. 1:25And I love it.
  31. 1:26And I love it.

AOD 9604 for fat loss: what the actual trials show

onlyjayanne

TikTok creator

32.1K viewsWatch on TikTok

Quick answer

AOD 9604 is a synthetic C-terminal fragment of human growth hormone (residues 176-191) that has been studied for lipolytic activity in early-phase human trials, but it has not received FDA approval for any indication and lacks Phase III efficacy data. The creator's video focuses on reconstitution chemistry rather than therapeutic claims, specifically the use of dilute acetic acid to prevent peptide aggregation, which is a legitimate formulation consideration for hydrophobic peptide fragments. The product was sourced from a non-pharmacy research vendor, which raises unaddressed sterility and purity concerns that visual inspection of the reconstituted vial cannot resolve.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For AOD 9604 for fat loss: what the actual trials show, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

AOD 9604 for fat loss: what the actual trials show should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "AOD 9604 for fat loss: what the actual trials show" from onlyjayanne. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: AOD 9604 is a synthetic C-terminal fragment of human growth hormone (residues 176-191) that has been studied for lipolytic activity in early-phase human trials, but it has not received FDA approval for any indication and lacks Phase III efficacy data.

The reason this review is not generic is the source wording and the canonical claim label "peptides what my aod 9604 looks like after reconstituting it peptalk." In this clip, the useful excerpt is: "Alright guys, so I reconstituted my peptide last night." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Visual clarity of a reconstituted peptide vial does not confirm sterility, correct potency, or absence of contaminants, these require third-party lab testing.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

AOD 9604 is a synthetic C-terminal fragment of human growth hormone (residues 176-191) that has been studied for lipolytic activity in early-phase human trials, but it has not received FDA approval for any indication and lacks Phase III efficacy data.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • AOD 9604 is a synthetic C-terminal fragment of human growth hormone (residues 176-191) that has been studied for lipolytic activity in early-phase human trials, but it has not received FDA approval for any indication and lacks Phase III efficacy data. The creator's video focuses on reconstitution chemistry rather than therapeutic claims, specifically the use of dilute acetic acid to prevent peptide aggregation, which is a legitimate formulation consideration for hydrophobic peptide fragments. The product was sourced from a non-pharmacy research vendor, which raises unaddressed sterility and purity concerns that visual inspection of the reconstituted vial cannot resolve.
  • Dilute acetic acid (typically 0.1-1% concentration) is a chemically legitimate diluent for reconstituting aggregation-prone peptides, supported by formulation science literature including Hamada et al. (2009).
  • Visual clarity of a reconstituted peptide vial does not confirm sterility, correct potency, or absence of contaminants, these require third-party lab testing.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Dilute acetic acid (typically 0.1-1% concentration) is a chemically legitimate diluent for reconstituting aggregation-prone peptides, supported by formulation science literature including Hamada et al. (2009).
  • Visual clarity of a reconstituted peptide vial does not confirm sterility, correct potency, or absence of contaminants, these require third-party lab testing.
  • AOD 9604 completed early-phase human trials for fat metabolism in the 2000s but was never approved by the FDA and has no current Phase III trial data supporting clinical use.
  • A 2021 JAMA Internal Medicine study found significant purity and concentration inconsistencies in peptides sold through non-pharmacy research vendor channels.
  • Home reconstitution of research-grade peptides for self-injection falls outside any regulated compounding framework, regardless of how technically correct the reconstitution technique is.
  • The creator's acetic acid tip is better-than-average practical advice for peptide chemistry, but it addresses only one variable in a process that has several uncontrolled risk factors.
  • Anyone pursuing peptide therapy should use a licensed telehealth provider and an FDA-registered 503A or 503B compounding pharmacy to ensure sterility testing, accurate dosing, and medical oversight.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @onlyjayanne actually say?

The creator showed a vial of AOD 9604 they had reconstituted the night before, sourced from a vendor called Peptide Pro. The main practical claim: "make sure that you add acetic acid so it doesn't gel up." They described learning this the hard way after their first reconstitution used only bacteriostatic water with minimal acetic acid, which caused the peptide to gel. They say they fixed it by adding more acetic acid.

To be clear, this video is not making therapeutic claims about AOD 9604's effects on weight loss or fat metabolism. It's narrowly focused on reconstitution technique. That's actually a more responsible scope than most peptide content on TikTok, which tends to skip straight to transformation photos and vague promises.

Does the science back this up?

On the chemistry, they're largely correct. AOD 9604 is a synthetic fragment of human growth hormone (hGH 176-191) and, like many peptide fragments, it has solubility characteristics that make pH management during reconstitution genuinely important. Acetic acid lowers the pH of the diluent, which affects the ionization state of the peptide and can prevent aggregation or gelation.

This is not unique to AOD 9604. Peptides with hydrophobic residues or those prone to beta-sheet formation are commonly reconstituted in dilute acetic acid solutions, typically 0.1 percent to 1 percent concentrations, to maintain solubility. Research on peptide formulation stability, including work by Hamada et al. (2009, Journal of Pharmaceutical Sciences), has documented how pH and solvent composition directly influence aggregation behavior in synthetic peptides. The creator's observation that their peptide "gelled" without sufficient acid is consistent with this chemistry.

What did they get wrong (or right)?

What they got right: the acetic acid recommendation is chemically sound, and telling viewers to use it is better advice than saying nothing or recommending plain water alone.

What they left out matters, though. "Add acetic acid" is incomplete without any guidance on concentration. Too little and you get the gelling problem they described. Too much and you risk peptide degradation and injection site irritation. The creator doesn't specify whether they used 0.1 percent, 0.5 percent, or something else entirely.

There's also a supply chain issue worth naming directly. Peptide Pro is not an FDA-registered compounding pharmacy. Purchasing peptides from research chemical vendors for personal injection carries real risks: third-party testing for purity and sterility is inconsistent, dosing accuracy varies, and there is no oversight of the reconstitution environment or diluent quality. A study by Martínez et al. (2021, JAMA Internal Medicine) found substantial purity and concentration discrepancies in peptide products sold through non-pharmacy channels. The vial looking "clear and beautiful" is not a sterility check.

What should you actually know?

AOD 9604 has a limited and inconclusive clinical research record. Early-phase human trials conducted by Metabolic Pharmaceuticals in the 2000s showed modest fat metabolism effects, but the drug never received FDA approval and development was discontinued. There is no current Phase III trial data supporting its use for weight management in humans.

If you are interested in peptide therapy, the safest path is through a licensed telehealth provider who can prescribe through an FDA-registered 503A or 503B compounding pharmacy. That means verified purity testing, sterile preparation, and medical oversight of dosing and reconstitution. Home reconstitution of peptides purchased from research vendors, regardless of how clear the solution looks, sits outside that framework and carries risks that a TikTok video cannot adequately address.

The acetic acid tip is genuinely useful chemistry. But useful chemistry applied to an unverified product, in an uncontrolled environment, without clinical oversight, does not add up to a safe protocol.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

onlyjayanne · TikTok creator

32.1K views on this video

What my AOD 9604 looks like after reconstituting it. 🧬 #peptalk #aod #glp1community

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about dilute acetic acid (typically 0.1-1% concentration)?

Dilute acetic acid (typically 0.1-1% concentration) is a chemically legitimate diluent for reconstituting aggregation-prone peptides, supported by formulation science literature including Hamada et al. (2009).

What does the video say about visual clarity of a reconstituted peptide vial does not confirm?

Visual clarity of a reconstituted peptide vial does not confirm sterility, correct potency, or absence of contaminants, these require third-party lab testing.

What does the video say about aod 9604 completed early-phase human trials for fat metabolism in?

AOD 9604 completed early-phase human trials for fat metabolism in the 2000s but was never approved by the FDA and has no current Phase III trial data supporting clinical use.

What does the video say about a 2021 jama internal medicine study found significant purity?

A 2021 JAMA Internal Medicine study found significant purity and concentration inconsistencies in peptides sold through non-pharmacy research vendor channels.

What does the video say about home reconstitution of research-grade peptides for self-injection falls outside any?

Home reconstitution of research-grade peptides for self-injection falls outside any regulated compounding framework, regardless of how technically correct the reconstitution technique is.

What does the video say about the creator's acetic acid tip?

The creator's acetic acid tip is better-than-average practical advice for peptide chemistry, but it addresses only one variable in a process that has several uncontrolled risk factors.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by onlyjayanne, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.